Robert Kistner

CFP Board Announces New Women's Initiative Endowed Scholarship

Retrieved on: 
Mardi, mars 28, 2023
CAE, Education, Woman, Research, Mentorship, Finance, History, WIN, Certification, Student, Certified Financial Planner Board of Standards, Cartier Women's Initiative Awards, Ecosystem, Caroline LeCount, Robert Kistner, Nursing

WASHINGTON, March 28, 2023 /PRNewswire/ -- CFP Board Center for Financial Planning ("Center") today announced the launch of an endowed scholarship program in recognition of the 10th anniversary of CFP Board's Women's Initiative (WIN): the WIN Endowed Scholarship program.

Key Points: 
  • WASHINGTON, March 28, 2023 /PRNewswire/ -- CFP Board Center for Financial Planning ("Center") today announced the launch of an endowed scholarship program in recognition of the 10th anniversary of CFP Board's Women's Initiative (WIN) : the WIN Endowed Scholarship program.
  • The WIN Endowed Scholarship program supports the next generation of women CFP® professionals who are committed to the practice of financial planning.
  • The WIN Endowed Scholarship program will award up to $5,000 per qualified student seeking to complete an undergraduate-level or a certificate-level CFP Board Registered Program.
  • The WIN Endowed Scholarship program is the second endowed scholarship offered by CFP Board, following last year's creation of the LeCount R. Davis, CFP® Scholarship , which honors the first Black CFP® professional.

Vizient to Present at FDA CDER Quality Management Maturity Workshop

Retrieved on: 
Mercredi, mai 25, 2022
Medical Supplies, Health, FDA, Hospitals, Practice Management, General Health, Pharmaceutical, CDER, Center for Drug Evaluation and Research, Food, Patient, Solution, FDA, Workshop, Center, Robert Kistner, Organization, Food and Drug Administration Amendments Act of 2007, QMM, Q&A, Quality Management Maturity Grid, Impact, Pharmaceutical industry, Research, Vizient, Inc.

Vizient Group Senior Vice President, Pharmacy Solutions Dan Kistner will present at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) Workshop , which is being held May 24-25, 2022.

Key Points: 
  • Vizient Group Senior Vice President, Pharmacy Solutions Dan Kistner will present at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) Workshop , which is being held May 24-25, 2022.
  • On the second day of the workshop titled, Development and Impact of Quality Ratings Systems, Kistner will share Vizients efforts to support a more resilient supply chain and how group purchasing organizations could utilize QMM ratings.
  • Concurrent to the QMM Workshop, the FDA is soliciting input from stakeholders until June 7, 2022 that will help to inform the future regulatory approach for a Quality Metrics Reporting Program to which Vizient plans to share comments.
  • Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume.

Vizient Pharmacy Market Outlook: Increased Use of Remdesivir for COVID Pushes it to Top Spot in Total Vizient Member Spend

Retrieved on: 
Mercredi, janvier 26, 2022
Hospitals, Health, Pharmaceutical, Practice Management, Medical Supplies, Pharmacy, Pembrolizumab, Industry, Projection, Adalimumab, Annual report, COVID, Hospital, FDA, Robert Kistner, Cancer, Growth, Ethisphere Institute, Health, Tocilizumab, Solution, Safety, Remdesivir, No, Pharmaceutical industry, Vizient, Inc.

Remdesivir, which came to market in 2020, currently makes up 3.42%, amounting to over $1 billion, of total Vizient member spend among all pharmaceuticals analyzed in the semi-annual report.

Key Points: 
  • Remdesivir, which came to market in 2020, currently makes up 3.42%, amounting to over $1 billion, of total Vizient member spend among all pharmaceuticals analyzed in the semi-annual report.
  • Before COVID, we anticipated adalimumab would remain the top drug by total spend until biosimilars are introduced to bring in competition in 2023, said Dan Kistner , Vizient group senior vice president for pharmacy.
  • 1 drug in total member spend across all classes of trade reflects how COVID has impacted hospitals and the unanticipated costs to their budgets.
  • Tocilizumab, also used in the treatment of COVID, earned a new spot within the top 10 list of overall drug spend among Vizient members, coming in at No.

Vizient Calls on Industry Stakeholders to Join Alliance to End Drug Shortages

Retrieved on: 
Lundi, novembre 8, 2021
Medical Supplies, Health, Hospitals, Practice Management, General Health, Pharmaceutical, Robert Kistner, Ethisphere Institute, Industry, USP, Organization, East End Drugs, Program, Hospital, Solution, State, Patient, Risk management, Medicine

Vizient, Inc. today announced the formation of a new alliance to end drug shortages in the U.S.

Key Points: 
  • Vizient, Inc. today announced the formation of a new alliance to end drug shortages in the U.S.
  • The End Drug Shortages Alliance will provide a forum for key stakeholders across the industry to take strategic aim at one of the health care industrys most pressing and enduring issues.
  • In 2019, a Vizient member survey revealed that managing drug shortages costs U.S. hospitals more than $359 million annually in labor alone.
  • The End Drug Shortages Alliance will formally bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions.

Vizient Announces Milestone in Fight to End Drug Shortages: 100 Million Additional Units of Essential Medications Through Novaplus Enhanced Supply Program in Under Two Years

Retrieved on: 
Mardi, octobre 26, 2021
Medical Supplies, Health, Hospitals, Practice Management, General Health, Pharmaceutical, Hospital, Robert Kistner, Ethisphere Institute, Patient, Program, Solution, Health, COVID, Propofol, Medical device, Pharmaceutical industry, Renewable energy, Vizient, Inc., Vizient Novaplus and the Novaplus Enhanced Supply Program, VIZIENT, INC., VIZIENT NOVAPLUS AND THE NOVAPLUS ENHANCED SUPPLY PROGRAM

Vizient, Inc. today announced its Novaplus Enhanced Supply Program has brought 100 million additional units of inventory of essential medications to the supply chain, many used to treat life-threatening illnesses.

Key Points: 
  • Vizient, Inc. today announced its Novaplus Enhanced Supply Program has brought 100 million additional units of inventory of essential medications to the supply chain, many used to treat life-threatening illnesses.
  • The Novaplus Enhanced Supply Program provides supply assurance for participating Vizient members through increased inventory commitment from suppliers and members for essential medications .
  • Through Novaplus Enhanced Supply program, 676,000 additional units of the sedative had already entered the market at the time of the spike.
  • Novaplus Enhanced Supply Program provides additional inventory of essential products through enhanced supplier partnerships to mitigate supply disruptions and demand surge.

New Vizient Data Estimates US Hospitals Spend $310 Million Annually on Management of 'White/Brown Bagging' Requirements for Specialty Pharmaceuticals

Retrieved on: 
Lundi, août 30, 2021
Hospitals, Health, Pharmaceutical, Practice Management, Medical Supplies, Robert Kistner, Ethisphere Institute, Cancer, Gaps, Policy, Physician, Time, Hospital, Health, Pembrokeshire Action To Combat Hardship, Refrigeration, Patient, Solution, Doctor of Pharmacy, COVID-19, Medicine

Brown bagging is when a patient acquires their medication from an external pharmacy and takes it to their provider for administration.

Key Points: 
  • Brown bagging is when a patient acquires their medication from an external pharmacy and takes it to their provider for administration.
  • Beyond those challenges and hardships, its impacting the crux of what hospitals do: provide patient care.
  • The issues encountered included: separate inventory management system, delivery location/security disruptions, lack of space to hold medication (e.g., refrigeration), etc.
  • Vizient has earned a Worlds Most Ethical Company designation from the Ethisphere Institute every year since its inception.